Does optimal TAD and quality of reduction minimize cut-out risks in patients with pertrochanteric femur fractures treated with the Elos intramedullary nail?
In pertrochanteric femur fractures treated with the Elos intramedullary nail, achieving a TAD ≤ 25 mm and excellent reduction quality is crucial to minimize cut-out complications.
This study indicates that optimal TAD and quality of reduction are crucial for minimizing cut-out risks. The Elos intramedullary nail shows favorable outcomes with a low cut-out incidence when these parameters are met. Emphasis should be placed on achieving a TAD ≤ 25 mm and excellent reduction quality to reduce complications.
Donadono et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: